Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

MAR 25, 2015 - Yahoo! News

A Must Read - Share

Amgen to appeal rejection of bid to block Novartis biosimilar drug

Amgen Inc will appeal the rejection of its bid to block the sale of Novartis AG's biosimilar form of Neupogen, Amgen's blockbuster drug used to prevent infections in cancer patients, according to a court filing on Wednesday. The drug, Zarxio, contains the same active ingredient as Amgen's $1.2 billion-a-year Neupogen, and once launched, would become the first biosimilar in the ...

Tags: Amgen to appeal rejection of bid to block Novartis biosimilar drug,  Amgen Latest News

MAR 19, 2015 - Reuters

A Must Read - Share

U.S. judge rejects Amgen bid to block 'biosimilar' Neupogen

NEW YORK (Reuters) - A U.S. judge on Thursday denied Amgen Inc's bid to block the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, Amgen's blockbuster drug used to prevent infections in cancer patients.

Tags: U.S. judge rejects Amgen bid to block 'biosimilar' Neupogen,  Amgen Latest News

MAR 19, 2015 - Reuters

A Must Read - Share

U.S. judge rejects Amgen bid to block biosimilar Neupogen

SAN FRANCISCO (Reuters) - A U.S. judge on Thursday denied Amgen Inc's bid to block the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, Amgen's blockbuster drug used to prevent infections in cancer patients.

Tags: U.S. judge rejects Amgen bid to block biosimilar Neupogen,  Amgen Latest News

MAR 16, 2015 - Huffington Post

A Must Read - Share

A New Class Of Experimental Cholesterol Drugs Are Outperforming Traditional Statins

SAN DIEGO (AP) — New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market. People taking one of these drugs had half the risk of dying or suffering ...

Tags: A New Class Of Experimental Cholesterol Drugs Are Outperforming Traditional Statins,  Amgen Latest News

MAR 15, 2015 - Yahoo! News

A Must Read - Share

Experimental cholesterol drugs cut heart risk, but questions remain

By Deena Beasley San Diego (Reuters) - Studies of a new class of experimental cholesterol-lowering drugs signal that they may reduce by half the risk of heart attack and other major cardiovascular problems compared to standard treatment alone. Doctors at the annual meeting of the American College of Cardiology, where the studies were presented, called the results "encouraging," but said ...

Tags: Experimental cholesterol drugs cut heart risk, but questions remain,  Amgen Latest News